Hypocalcemia due to avid calcium uptake by osteoblastic metastases of prostate cancer.
作者信息
Szentirmai M, Constantinou C, Rainey J M, Loewenstein J E
机构信息
Department of Medicine, Meridia Huron Hospital, Cleveland, OH 44112, USA.
出版信息
West J Med. 1995 Dec;163(6):577-8.
Abstract
摘要
相似文献
1
Hypocalcemia due to avid calcium uptake by osteoblastic metastases of prostate cancer.
West J Med. 1995 Dec;163(6):577-8.
2
Severe hypocalcaemia associated with extensive osteoblastic metastases in a patient with prostate cancer.
Neth J Med. 2005 Jan;63(1):34-7.
3
Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease.
Prostate Cancer Prostatic Dis. 2009;12(1):94-9. doi: 10.1038/pcan.2008.10. Epub 2008 Mar 11.
4
Prolonged hypocalcemia after zoledronic acid in a patient with metastatic prostate carcinoma: did zoledronic acid trigger osteoblastic activity and avid calcium uptake?
Clin Genitourin Cancer. 2012 Mar;10(1):50-3. doi: 10.1016/j.clgc.2011.11.004. Epub 2012 Jan 14.
5
Zoledronic acid-induced severe hypocalcaemia in a prostate cancer patient with extensive osteoblastic bone metastases.
Tenn Med. 2005 Feb;98(2):83-5, 89.
6
A man with osteoblastic metastasis and hypocalcaemia.
Singapore Med J. 2000 Feb;41(2):74-6.
7
Severe hypocalcaemia because of osteoblastic prostate carcinoma metastases.
Int J Clin Pract. 2008 Oct;62(10):1630-1. doi: 10.1111/j.1742-1241.2008.01802.x.
8
Metabolic studies in a case of hypocalcemia and osteoblastic metastases.
Arch Intern Med. 1979 Feb;139(2):238-41.
9
Prostate cancer bone metastases promote both osteolytic and osteoblastic activity.
J Cell Biochem. 2004 Mar 1;91(4):718-29. doi: 10.1002/jcb.10662.
10
Autoradiographic studies of rhenium-188-hydroxyethylidine diphosphonate in normal skeleton and osteoblastic bone metastases in a rat model of metastatic prostate cancer.
Nucl Med Commun. 2009 Sep;30(9):693-9. doi: 10.1097/MNM.0b013e32832cc23c.
引用本文的文献
1
Hungry bone syndrome secondary to prostate cancer successfully treated with radium therapy.
BMJ Case Rep. 2018 Jul 6;2018:bcr-2018-225039. doi: 10.1136/bcr-2018-225039.
2
Biomarkers of Prostatic Cancer: An Attempt to Categorize Patients into Prostatic Carcinoma, Benign Prostatic Hyperplasia, or Prostatitis Based on Serum Prostate Specific Antigen, Prostatic Acid Phosphatase, Calcium, and Phosphorus.
Prostate Cancer. 2017;2017:5687212. doi: 10.1155/2017/5687212. Epub 2017 Jan 12.
3
Hypercalcaemia and hypocalcaemia: finding the balance.
Support Care Cancer. 2017 May;25(5):1639-1649. doi: 10.1007/s00520-016-3543-1. Epub 2017 Jan 12.
4
Paraneoplastic hypocalcemia-induced heart failure in advanced breast cancer: A case report and literature review.
Oncol Lett. 2015 Aug;10(2):773-777. doi: 10.3892/ol.2015.3326. Epub 2015 Jun 5.
本文引用的文献
1
Cancer statistics, 1993.
CA Cancer J Clin. 1993 Jan-Feb;43(1):7-26. doi: 10.3322/canjclin.43.1.7.
2
Hypophosphatemic osteomalacia: association with prostatic carcinoma.
Ann Intern Med. 1980 Aug;93(2):275-8. doi: 10.7326/0003-4819-93-2-275.
3
Hypocalcemia with osteoblastic metastases in patient with prostate carcinoma. A cause of secondary hyperparathyroidism.
Am J Med. 1981 Jul;71(1):184-8. doi: 10.1016/0002-9343(81)90292-8.
4
Oncogenous osteomalacia. Review of the world literature of 42 cases and report of two new cases.
Am J Med. 1984 Sep;77(3):501-12. doi: 10.1016/0002-9343(84)90112-8.
5
Hypocalcemia associated with metastatic bone disease. A retrospective study.
Arch Intern Med. 1973 Oct;132(4):539-43.
6
Hypocalcemia in patients with prostate cancer.
Calcif Tissue Int. 1988 Dec;43(6):340-5. doi: 10.1007/BF02553276.
7
The clinical spectrum of hypocalcaemia associated with bone metastases.
J Intern Med. 1989 Dec;226(6):449-52. doi: 10.1111/j.1365-2796.1989.tb01423.x.
8
Metabolic studies in a case of hypocalcemia and osteoblastic metastases.
Arch Intern Med. 1979 Feb;139(2):238-41.
Zotero 插件